Litcius/Paper detail

Comparison of Collagenase <i>Clostridium histolyticum</i> to Surgery for the Management of Peyronie’s Disease: A Randomized Trial

Benjamin Green, Ashley Flores, Jacob Warner, Tobias Köhler, Sevann Helo, Landon Trost

2023The Journal of Urology19 citationsDOIOpen Access PDF

Abstract

PURPOSE: for Peyronie's disease, there has been significant debate regarding its role and comparable efficacy to surgery. MATERIALS AND METHODS: + RestoreX penile traction therapy + sildenafil or penile surgery + RestoreX penile traction therapy + sildenafil, with 3-month data presented. Primary objectives were overall satisfaction, subjective changes in erectile function, penile sensation, penile length, and changes in the International Index of Erectile Function-Erectile Function Domain score. Secondary outcomes included objective changes in length, curve, adverse events, and other standardized and nonstandardized questionnaires. RESULTS: < .01). CONCLUSIONS: + RestoreX penile traction therapy + sildenafil results in lesser curve improvements but greater penile length and fewer adverse events, including impacts on subjective erectile function and sensation, than men treated with surgery.

Topics & Concepts

MedicinePeyronie's diseaseErectile dysfunctionErectile functionUrologyAdverse effectRandomized controlled trialSurgeryInternal medicineSexual function and dysfunction studiesGenital Health and DiseaseUrinary Bladder and Prostate Research
Comparison of Collagenase <i>Clostridium histolyticum</i> to Surgery for the Management of Peyronie’s Disease: A Randomized Trial | Litcius